The Bharat Immunological and Biological Corporation limited (BIBCOl) unit of Union Government, in Bulandshahr which stopped functioning many years ago will start production of vaccines in association with Institute for Translation Vaccineology of Netherlands from this year. District Magistrate Bulandshahr B Chandrakala said in a statement that a Memorandum of Understanding (MoU) was signed between BIBCOl's chairman M K Bhan, Principal Secretary for Bio-technology department Vijay Raghvan and INTRAVEK's N C Odys for starting the production of BIBCOl measels and Ruvela vaccines with an investment of Rs 200 crores from this year.
BIBCOl's chairman of workers union Anekpal Singh here said that the unit was started in 1988 by then Prime Minister Rajeev Gandhi and at that time over 100 millions of polio vaccines were being manufactured in this plant. “This plant was closed due to various reasons. With the initiatives of both the Governments – centre and state – the unit will start working soon. It will generate employment opportunity and bring this region into the industrial map of the state,” he said.
BIBCOl is a leading biotechnology company based which manufactures and produces a range of pharmaceuticals products such as Oral Polio Vaccines (OPV Vaccine), Zinc Tablet & Diarrhea Management Kit. Singh said that BIBCOl’s principal mission is to save the lives of millions of children from avoidable disability, through polio vaccination. Since its inception, it has contributed significantly to the eradication of Poliomyelitis in the country through the National Immunization Program.